Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis | Zendy

Don Pham | Zendy; Daniel Addison | Zendy; Waleed T. Kayani | Zendy; Arunima Misra | Zendy; Hani Jneid | Zendy; Jon R. Resar | Zendy; Nassir Lakkis | Zendy; Mahboob Alam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis

Author(s) -

Don Pham,

Daniel Addison,

Waleed T. Kayani,

Arunima Misra,

Hani Jneid,

Jon R. Resar,

Nassir Lakkis,

Mahboob Alam

Publication year - 2018

Publication title -

emergency medicine journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.708

H-Index - 81

eISSN - 1472-0213

pISSN - 1472-0205

DOI - 10.1136/emermed-2017-207065

Subject(s) - medicine , meta analysis , chest pain , beta blocker , anesthesia , cocaine use , adrenergic beta antagonists , emergency department , medline , emergency medicine , psychiatry , heart failure , political science , law , propranolol

Beta blockers (β-blockers) remain a standard therapy in the early treatment of acute coronary syndromes. However, β-blocker therapy in patients with cocaine-associated chest pain (CACP) continues to be an area of debate due to the potential risk of unopposed α-adrenergic stimulation and coronary vasospasm. Therefore, we performed a systematic review and meta-analysis of available studies to compare outcomes of β-blocker versus no β-blocker use among patients with CACP.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research